A 24 month, randomized, controlled, study to evaluate the efficacy and safety of concentrationcontrolled everolimus plus reduced tacrolimus compared to standard tacrolimus in recipients of living donor liver transplants
|Effective start/end date||4/1/14 → 2/15/19|
- NOVARTIS PHARMACEUTICALS CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.